Resmed Inc. buy KeyCorp
Start price
25.10.24
/
50%
€237.10
Target price
25.10.25
€246.13
Performance (%)
-6.03%
End price
26.10.25
€222.80
Summary
This prediction ended on 26.10.25 with a price of €222.80. With a performance of -6.03%, the BUY prediction for Resmed Inc. by KeyCorp closed slightly in the red. KeyCorp has a follow-up prediction for Resmed Inc. where he still thinks Resmed Inc. is a Buy. Dividends of €1.00 are taken into consideration when calculating the performance. KeyCorp has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Resmed Inc. | 6.519% | 6.519% | -23.206% |
| iShares Core DAX® | 2.591% | 2.691% | 6.411% |
| iShares Nasdaq 100 | -0.915% | -7.368% | 20.651% |
| iShares Nikkei 225® | 0.145% | -10.196% | 46.169% |
| iShares S&P 500 | -0.367% | -0.833% | 18.019% |
Comments by KeyCorp for this prediction
In the thread Resmed Inc. diskutieren
ResMed Inc. (NYSE: RMD) had its price target raised by analysts at KeyCorp from $251.00 to $266.00. They now have an "overweight" rating on the stock.
Ratings data for RMD provided by MarketBeat
In the thread Trading Resmed Inc.
Die von KeyCorp gewählte maximale Laufzeit wurde überschritten